These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29189693)

  • 21. Surveillance for anencephaly and spina bifida and the impact of prenatal diagnosis--United States, 1985-1994.
    Cragan JD; Roberts HE; Edmonds LD; Khoury MJ; Kirby RS; Shaw GM; Velie EM; Merz RD; Forrester MB; Williamson RA; Krishnamurti DS; Stevenson RE; Dean JH
    MMWR CDC Surveill Summ; 1995 Aug; 44(4):1-13. PubMed ID: 7637675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prenatal screening and diagnosis of neural tube defects.
    Cameron M; Moran P
    Prenat Diagn; 2009 Apr; 29(4):402-11. PubMed ID: 19301349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amniotic-fluid alpha-fetoprotein measurement in antenatal diagnosis of anencephaly and open spina bifida in early pregnancy. Second report of the U.K. Collaborative Study on Alpha-fetoprotein in Relation to Neural-tube Defects.
    Lancet; 1979 Sep; 2(8144):651-62. PubMed ID: 90757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Routine ultrasonography compared with maternal serum alpha-fetoprotein for neural tube defect screening.
    Norem CT; Schoen EJ; Walton DL; Krieger RC; O'Keefe J; To TT; Ray GT
    Obstet Gynecol; 2005 Oct; 106(4):747-52. PubMed ID: 16199631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antecedent circumstances surrounding neural tube defect births in 1990-1991. The Steering Committee of the National Confidential Enquiry into Counselling for Genetic Disorders.
    Williamson P; Alberman E; Rodeck C; Fiddler M; Church S; Harris R
    Br J Obstet Gynaecol; 1997 Jan; 104(1):51-6. PubMed ID: 8988697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival of infants with neural tube defects in the presence of folic acid fortification.
    Bol KA; Collins JS; Kirby RS;
    Pediatrics; 2006 Mar; 117(3):803-13. PubMed ID: 16510661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and prevention of neural tube defects.
    Birnbacher R; Messerschmidt AM; Pollak AP
    Curr Opin Urol; 2002 Nov; 12(6):461-4. PubMed ID: 12409872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study on key techniques and intervention in reducing birth defects].
    Zhu BS; Su J; Lu XH; He J; Zhu S; Jiao CX; Zhang JM; Tang XH; Tao Y; Lin KP; Chen H; Li SY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):658-63. PubMed ID: 22176989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Periodic health examination, 1994 update: 3. Primary and secondary prevention of neural tube defects. Canadian Task Force on the Periodic Health Examination.
    CMAJ; 1994 Jul; 151(2):159-66. PubMed ID: 7518734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of neural tube defects in South Australia, 1966-91: effectiveness and impact of prenatal diagnosis.
    Chan A; Robertson EF; Haan EA; Keane RJ; Ranieri E; Carney A
    BMJ; 1993 Sep; 307(6906):703-6. PubMed ID: 8401091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management issues for women with epilepsy: neural tube defects and folic acid supplementation.
    Yerby MS
    Neurology; 2003 Sep; 61(6 Suppl 2):S23-6. PubMed ID: 14504306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neural tube defects in Australia: trends in encephaloceles and other neural tube defects before and after promotion of folic acid supplementation and voluntary food fortification.
    Bower C; D'Antoine H; Stanley FJ
    Birth Defects Res A Clin Mol Teratol; 2009 Apr; 85(4):269-73. PubMed ID: 19180646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of folic acid for prevention of spina bifida and other neural tube defects--1983-1991.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1991 Aug; 40(30):513-6. PubMed ID: 2072886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sonography of fetal cerebrospinal anomalies.
    Pilu G; Hobbins JC
    Prenat Diagn; 2002 Apr; 22(4):321-30. PubMed ID: 11981913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of folic acid for the prevention of neural tube defects and other congenital anomalies.
    Wilson RD; Davies G; Désilets V; Reid GJ; Summers A; Wyatt P; Young D;
    J Obstet Gynaecol Can; 2003 Nov; 25(11):959-73. PubMed ID: 14608448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prenatal diagnosis of neural tube defects. IV. Maternal serum alpha-fetoprotein screening.
    Milunsky A; Alpert E; Neff RK; Frigoletto FD
    Obstet Gynecol; 1980 Jan; 55(1):60-6. PubMed ID: 6153240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neural tube defects: issues in prenatal diagnosis and counselling.
    Main DM; Mennuti MT
    Obstet Gynecol; 1986 Jan; 67(1):1-16. PubMed ID: 2415888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of folic acid fortification on the reduction of neural tube defects].
    Santos LM; Pereira MZ
    Cad Saude Publica; 2007 Jan; 23(1):17-24. PubMed ID: 17187100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results and benefits of a maternal serum alpha-fetoprotein screening program.
    Milunsky A; Alpert E
    JAMA; 1984 Sep; 252(11):1438-42. PubMed ID: 6206249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A decreasing rate of neural tube defects following the recommendations for periconceptional folic acid supplementation.
    Klusmann A; Heinrich B; Stöpler H; Gärtner J; Mayatepek E; Von Kries R
    Acta Paediatr; 2005 Nov; 94(11):1538-42. PubMed ID: 16303691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.